基于人类胎盘干细胞的治疗方法,以预防腹部粘附:一项前性随机预临床试验
Samuel P Carmichael1, Prafulla K Chandra, John W Vaughan
1From the Department of Surgery (S.P.C.), Institute for Regenerative Medicine (S.P.C., P.K.C., J.W.V., A.A.), and Division of Public Health Sciences, Department of Biostatistics and Data Science (D.M.K.), Wake Forest School of Medicine, Winston-Salem, North Carolina; and Department of Surgery (J.B.H.), University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
The journal of trauma and acute care surgery
|December 18, 2024
概括
在大鼠模型中,人类胎盘干细胞疗法通过减少纤维化组织的形成和抑制益纤维化基因,有效地防止腹部粘附. 这些发现支持用于术后粘附预防的新型治疗策略.
科学领域:
- 再生医学是一种再生医学.
- 手术创新 在外科创新.
- 生物材料科学 生物材料科学
背景情况:
- 腹部粘附,手术后形成的纤维组织,可以导致肠道阻塞等并发症.
- 现有的治疗方法在防止整个腹部粘附方面缺乏一致的有效性.
- 人类胎盘干细胞 (hPSCs) 具有抗炎性质,对纤维状况有益.
研究的目的:
- 评估基于hPSC的治疗方法,以预防腹部粘附.
- 在临床相关的老鼠模型中测试这些疗法.
主要方法:
- 54只老鼠接受了粘附模型的创建,并接受了各种治疗,包括hPSCs,水凝中的hPSCs,秘密和对照.
- 治疗是通过腹膜内进行的;粘附在14天后得到了分数.
- 通过基因组和组织学分析研究了分子机制.
主要成果:
- 氨酸水凝,HA-Mal-CM水凝和Seprafilm显著降低了整体粘附得分.
- hPSCs,HA-Mal-hPSC水凝,HA-Mal-CM水凝,HA-Mal水凝和Seprafilm在腹腔组织中降低了原蛋白含量.
- hPSCs和HA-Mal-hPSC水凝抑制了关键的益纤维素基因表达.
结论:
- 在临床前试验中,基于hPSC的疗法在减少腹部粘附方面表现出有效性.
- 这些治疗效应与抑制profibrotic基因组和蛋白质组途径有关.
相关概念视频
Embryonic Stem Cells
26.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
26.4K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K


